Steven Cohen Ocular Therapeutix, Inc Transaction History
Point72 Asset Management, L.P.
- $42.2 Billion
- Q4 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 2,935,924 shares of OCUL stock, worth $17.4 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,935,924
Previous 2,040,620
43.87%
Holding current value
$17.4 Million
Previous $17.8 Million
41.23%
% of portfolio
0.06%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding OCUL
# of Institutions
190Shares Held
132MCall Options Held
374KPut Options Held
179K-
Summer Road LLC West Palm Beach, FL13.9MShares$82.2 Million98.85% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.8MShares$76.1 Million4.83% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$75.7 Million17.98% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$68.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.48MShares$50.3 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $456M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...